Welcome!

News Feed Item

Renal Pain Global Clinical Trials Review, H2, 2014

LONDON, Aug. 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Renal Pain Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/703965/Renal-Pain-Global-Clinical-Trials-Review-H2-2014.html

Renal Pain Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Renal Pain Global Clinical Trials Review, H2, 2014" provides data on the Renal Pain clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Renal Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Renal Pain. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Renal Pain 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Renal Pain to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Renal Pain to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Renal Pain 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Renal Pain Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Pfizer Inc. 30
Clinical Trial Overview of Pfizer Inc. 30
Emcure Pharmaceuticals Ltd. 31
Clinical Trial Overview of Emcure Pharmaceuticals Ltd. 31
Clinical Trial Overview of Top Institutes / Government 32
Tehran University of Medical Sciences 32
Clinical Trial Overview of Tehran University of Medical Sciences 32
Seoul National University Hospital 33
Clinical Trial Overview of Seoul National University Hospital 33
University of Minnesota 34
Clinical Trial Overview of University of Minnesota 34
The International Kidney Stone Institute 35
Clinical Trial Overview of The International Kidney Stone Institute 35
Yale University 36
Clinical Trial Overview of Yale University 36
Ahvaz Jundishapur University of Medical Sciences 37
Clinical Trial Overview of Ahvaz Jundishapur University of Medical Sciences 37
Isfahan University of Medical Sciences 38
Clinical Trial Overview of Isfahan University of Medical Sciences 38
Department of Health, UK 39
Clinical Trial Overview of Department of Health, UK 39
University of Monastir 40
Clinical Trial Overview of University of Monastir 40
Korea Institute of Oriental Medicine 41
Clinical Trial Overview of Korea Institute of Oriental Medicine 41
Five Key Clinical Profiles 42
Appendix 62
Abbreviations 62
Definitions 62
Research Methodology 63
Secondary Research 63
About GlobalData 64
Contact Us 64
Disclaimer 64
Source 64

List of Tables

Renal Pain Therapeutics, Global, Clinical Trials by Region, 2014* 7
Renal Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Renal Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Renal Pain Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Renal Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Renal Pain Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Renal Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Renal Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Renal Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Renal Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Renal Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Renal Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Renal Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Renal Pain Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Renal Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Renal Pain Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Renal Pain Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Renal Pain Therapeutics, Global, Suspended Clinical Trials, 2014* 24
Renal Pain Therapeutics, Global, Withdrawn Clinical Trials, 2014* 24
Renal Pain Therapeutics, Global, Terminated Clinical Trials, 2014* 24
Renal Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Renal Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Renal Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Renal Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Renal Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 30
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Emcure Pharmaceuticals Ltd., 2014* 31
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014* 32
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2014* 33
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2014* 34
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by The International Kidney Stone Institute, 2014* 35
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2014* 36
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Ahvaz Jundishapur University of Medical Sciences, 2014* 37
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2014* 38
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2014* 39
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Monastir, 2014* 40
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Korea Institute of Oriental Medicine, 2014* 41

List of Figures

Renal Pain Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Renal Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Renal Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Renal Pain Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Renal Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Renal Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Renal Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Renal Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Renal Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Renal Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Renal Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Renal Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Renal Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Renal Pain Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Renal Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Renal Pain Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Renal Pain Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Renal Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Renal Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Renal Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Renal Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Renal Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 63


Read the full report:
Renal Pain Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/703965/Renal-Pain-Global-Clinical-Trials-Review-H2-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Companies are harnessing data in ways we once associated with science fiction. Analysts have access to a plethora of visualization and reporting tools, but considering the vast amount of data businesses collect and limitations of CPUs, end users are forced to design their structures and systems with limitations. Until now. As the cloud toolkit to analyze data has evolved, GPUs have stepped in to massively parallel SQL, visualization and machine learning.
The session is centered around the tracing of systems on cloud using technologies like ebpf. The goal is to talk about what this technology is all about and what purpose it serves. In his session at 21st Cloud Expo, Shashank Jain, Development Architect at SAP, will touch upon concepts of observability in the cloud and also some of the challenges we have. Generally most cloud-based monitoring tools capture details at a very granular level. To troubleshoot problems this might not be good enough.
DevOps is under attack because developers don’t want to mess with infrastructure. They will happily own their code into production, but want to use platforms instead of raw automation. That’s changing the landscape that we understand as DevOps with both architecture concepts (CloudNative) and process redefinition (SRE). Rob Hirschfeld’s recent work in Kubernetes operations has led to the conclusion that containers and related platforms have changed the way we should be thinking about DevOps and...
When it comes to cloud computing, the ability to turn massive amounts of compute cores on and off on demand sounds attractive to IT staff, who need to manage peaks and valleys in user activity. With cloud bursting, the majority of the data can stay on premises while tapping into compute from public cloud providers, reducing risk and minimizing need to move large files. In his session at 18th Cloud Expo, Scott Jeschonek, Director of Product Management at Avere Systems, discussed the IT and busine...
SYS-CON Events announced today that Dasher Technologies will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Dasher Technologies, Inc. ® is a premier IT solution provider that delivers expert technical resources along with trusted account executives to architect and deliver complete IT solutions and services to help our clients execute their goals, plans and objectives. Since 1999, we'v...
Enterprises have taken advantage of IoT to achieve important revenue and cost advantages. What is less apparent is how incumbent enterprises operating at scale have, following success with IoT, built analytic, operations management and software development capabilities – ranging from autonomous vehicles to manageable robotics installations. They have embraced these capabilities as if they were Silicon Valley startups. As a result, many firms employ new business models that place enormous impor...
We all know that end users experience the Internet primarily with mobile devices. From an app development perspective, we know that successfully responding to the needs of mobile customers depends on rapid DevOps – failing fast, in short, until the right solution evolves in your customers' relationship to your business. Whether you’re decomposing an SOA monolith, or developing a new application cloud natively, it’s not a question of using microservices – not doing so will be a path to eventual b...
SYS-CON Events announced today that Massive Networks, that helps your business operate seamlessly with fast, reliable, and secure internet and network solutions, has been named "Exhibitor" of SYS-CON's 21st International Cloud Expo ®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. As a premier telecommunications provider, Massive Networks is headquartered out of Louisville, Colorado. With years of experience under their belt, their team of...
SYS-CON Events announced today that TidalScale, a leading provider of systems and services, will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. TidalScale has been involved in shaping the computing landscape. They've designed, developed and deployed some of the most important and successful systems and services in the history of the computing industry - internet, Ethernet, operating s...
SYS-CON Events announced today that Taica will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Taica manufacturers Alpha-GEL brand silicone components and materials, which maintain outstanding performance over a wide temperature range -40C to +200C. For more information, visit http://www.taica.co.jp/english/.
SYS-CON Events announced today that MIRAI Inc. will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. MIRAI Inc. are IT consultants from the public sector whose mission is to solve social issues by technology and innovation and to create a meaningful future for people.
Transforming cloud-based data into a reportable format can be a very expensive, time-intensive and complex operation. As a SaaS platform with more than 30 million global users, Cornerstone OnDemand’s challenge was to create a scalable solution that would improve the time it took customers to access their user data. Our Real-Time Data Warehouse (RTDW) process vastly reduced data time-to-availability from 24 hours to just 10 minutes. In his session at 21st Cloud Expo, Mark Goldin, Chief Technolo...
SYS-CON Events announced today that IBM has been named “Diamond Sponsor” of SYS-CON's 21st Cloud Expo, which will take place on October 31 through November 2nd 2017 at the Santa Clara Convention Center in Santa Clara, California.
SYS-CON Events announced today that TidalScale will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. TidalScale is the leading provider of Software-Defined Servers that bring flexibility to modern data centers by right-sizing servers on the fly to fit any data set or workload. TidalScale’s award-winning inverse hypervisor technology combines multiple commodity servers (including their ass...
In the fast-paced advances and popularity in cloud technology, one of the most critical factors revolves around concerns for security of your critical data. How to assure both your company and your customers they can confidently trust and utilize your cloud environment is most often top on the list. There is a method to evaluating and providing security that exceeds conventional modes of protecting data both within the cloud as well externally on mobile and other devices. With the public failure...